Aayush Wellness Limited's shares surged 9% to ₹39 on April 24, 2024, marking a three-month high despite a broader market sell-off. This increase follows a two-day cumulative rise of 21%. The company's recent launch of Liver Care Tablets aims to address rising liver health concerns linked to modern lifestyles. Naveenakumar, Managing Director, emphasized the importance of liver health and the integration of Ayurvedic wisdom into their products. The nutraceutical market in India, valued at approximately $18 billion, is experiencing robust growth, driven by health awareness and rising disposable incomes. Aayush Wellness has rebounded 41.2% in April after a prolonged decline, and its stock has delivered an astonishing 3,219% return in CY24 alone, with nearly 3,000% growth over the past three years. Investors are advised to consult experts before making investment decisions.